Search

Search Constraints

You searched for: Author/Creator Klotsche, Jens

Search Results

1. 06.14 Proteasome inhibition with bortezomib in sle promotes therapeutically relevant depletion of short- and long-lived plasma cells but does not prevent their regeneration. (1st March 2017)

2. A3.26 Proteasome inhibition with bortezomib in refractory SLE inhibits type I interferon and depletes plasma cells but does not inhibit their regeneration. (31st January 2014)

3. AB0396 MONITORING OF PATIENTS WITH RHEUMATOID ARTHRITIS BY INDOCYANINE GREEN (ICG) ENHANCED FLUORESCENCE OPTICAL IMAGING TREATED WITH ANTI-TNFI THERAPY. (June 2019)

4. AB0967 IS THERE A DIFFERENCE IN PRESENTATION OF FEMALE AND MALE PATIENTS WITH JUVENILE SYSTEMIC SCLERODERMA. AN UPDATE FROM THE JUVENILE SYSTEMIC SCLERODERMA INCEPTION COHORT. WWW.JUVENILE-SCLERODERMA.COM. (June 2019)

5. AB1165 FLUORESCENCE OPTICAL IMAGING XIRALITE® IS HELPFUL IN THE DECISION FOR RITUXIMAB RE-THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS. (June 2019)

6. Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium. Issue 10215 (14th December 2019)

7. Are diffuse and limited juvenile systemic sclerosis different in clinical presentation? Clinical characteristics of a juvenile systemic sclerosis cohort. Issue 1 (February 2019)

8. Burden of comorbid conditions in children and young people with juvenile idiopathic arthritis: a collaborative analysis of 3 JIA registries. (6th October 2021)

10. Coexistence of calcified- and lipid-containing plaque components and their association with incidental rupture points in acute coronary syndrome-causing culprit lesions: results from the prospective OPTICO-ACS study. (14th December 2021)